298 related articles for article (PubMed ID: 31965953)
21. Advances in new target molecules against schistosomiasis: A comprehensive discussion of physiological structure and nutrient intake.
Zhu P; Wu K; Zhang C; Batool SS; Li A; Yu Z; Huang J
PLoS Pathog; 2023 Jul; 19(7):e1011498. PubMed ID: 37498810
[TBL] [Abstract][Full Text] [Related]
22. Schistosomiasis.
Gryseels B
Infect Dis Clin North Am; 2012 Jun; 26(2):383-97. PubMed ID: 22632645
[TBL] [Abstract][Full Text] [Related]
23. Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies.
Xiao SH
Parasitol Res; 2013 Nov; 112(11):3723-40. PubMed ID: 23979493
[TBL] [Abstract][Full Text] [Related]
24. Schistosomiasis Consortium for Operational Research and Evaluation (SCORE): Its Foundations, Development, and Evolution.
Colley DG; Jacobson JA; Binder S
Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):5-13. PubMed ID: 32400343
[TBL] [Abstract][Full Text] [Related]
25. Schistosomiasis-from immunopathology to vaccines.
McManus DP; Bergquist R; Cai P; Ranasinghe S; Tebeje BM; You H
Semin Immunopathol; 2020 Jun; 42(3):355-371. PubMed ID: 32076812
[TBL] [Abstract][Full Text] [Related]
26. A summary of the efficacy of praziquantel against schistosomes in animal experiments and notes on its mode of action.
Andrews P
Arzneimittelforschung; 1981; 31(3a):538-41. PubMed ID: 7016122
[TBL] [Abstract][Full Text] [Related]
27. Praziquantel: a new hope for schistosomiasis.
Lancet; 1980 Mar; 1(8169):635-6. PubMed ID: 6102634
[No Abstract] [Full Text] [Related]
28. Interrupting seasonal transmission of Schistosoma haematobium and control of soil-transmitted helminthiasis in northern and central Côte d'Ivoire: a SCORE study protocol.
Tian-Bi YT; Ouattara M; Knopp S; Coulibaly JT; Hürlimann E; Webster B; Allan F; Rollinson D; Meïté A; Diakité NR; Konan CK; N'Goran EK; Utzinger J
BMC Public Health; 2018 Jan; 18(1):186. PubMed ID: 29378542
[TBL] [Abstract][Full Text] [Related]
29. Elimination of schistosomiasis requires multifactorial diagnostics: evidence from high- and low-prevalence areas in the Nile Delta, Egypt.
Elmorshedy H; Bergquist R; Fayed A; Guirguis W; Abdel-Gawwad E; Eissa S; Barakat R
Infect Dis Poverty; 2020 Apr; 9(1):31. PubMed ID: 32241298
[TBL] [Abstract][Full Text] [Related]
30. Comparative evaluation of Schistosoma mansoni, Schistosoma intercalatum, and Schistosoma haematobium alkaline phosphatase antigenicity by the alkaline phosphatase immunoassay (APIA).
Cesari IM; Ballén DE; Mendoza L; Ferrer A; Pointier JP; Kombila M; Richard-Lenoble D; Théron A
Parasitol Res; 2014 Apr; 113(4):1395-403. PubMed ID: 24452918
[TBL] [Abstract][Full Text] [Related]
31. Current status of vaccines for schistosomiasis.
McManus DP; Loukas A
Clin Microbiol Rev; 2008 Jan; 21(1):225-42. PubMed ID: 18202444
[TBL] [Abstract][Full Text] [Related]
32. Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.
Karmakar S; Zhang W; Ahmad G; Torben W; Alam MU; Le L; Damian RT; Wolf RF; White GL; Carey DW; Carter D; Reed SG; Siddiqui AA
Vaccine; 2014 Mar; 32(11):1296-303. PubMed ID: 24397898
[TBL] [Abstract][Full Text] [Related]
33. A pilot control trial of schistosomiasis in central Liberia by mass chemotherapy of target populations, combined with focal application of molluscicide.
Saladin B; Saladin K; Holzer B; Dennis E; Hanson A; Degrémont A
Acta Trop; 1983 Sep; 40(3):271-95. PubMed ID: 6138977
[TBL] [Abstract][Full Text] [Related]
34. Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of
King CH; Kittur N; Binder S; Campbell CH; N'Goran EK; Meite A; Utzinger J; Olsen A; Magnussen P; Kinung'hi S; Fenwick A; Phillips AE; Gazzinelli-Guimaraes PH; Dhanani N; Ferro J; Karanja DMS; Mwinzi PNM; Montgomery SP; Wiegand RE; Secor WE; Hamidou AA; Garba A; Colley DG
Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):14-23. PubMed ID: 32400356
[TBL] [Abstract][Full Text] [Related]
35. Anti-schistosomal activities of quinoxaline-containing compounds: From hit identification to lead optimisation.
Padalino G; El-Sakkary N; Liu LJ; Liu C; Harte DSG; Barnes RE; Sayers E; Forde-Thomas J; Whiteland H; Bassetto M; Ferla S; Johnson G; Jones AT; Caffrey CR; Chalmers I; Brancale A; Hoffmann KF
Eur J Med Chem; 2021 Dec; 226():113823. PubMed ID: 34536671
[TBL] [Abstract][Full Text] [Related]
36. Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals.
Utzinger J; Chollet J; You J; Mei J; Tanner M; Xiao S
Acta Trop; 2001 Sep; 80(1):9-18. PubMed ID: 11495639
[TBL] [Abstract][Full Text] [Related]
37. Schistosomiasis: Drugs used and treatment strategies.
Siqueira LDP; Fontes DAF; Aguilera CSB; Timóteo TRR; Ângelos MA; Silva LCPBB; de Melo CG; Rolim LA; da Silva RMF; Neto PJR
Acta Trop; 2017 Dec; 176():179-187. PubMed ID: 28803725
[TBL] [Abstract][Full Text] [Related]
38. Some facts on south asian schistosomiasis and need for international collaboration.
Agrawal MC; Rao VG
Acta Trop; 2018 Apr; 180():76-80. PubMed ID: 29273443
[TBL] [Abstract][Full Text] [Related]
39. Praziquantel for the treatment of schistosomiasis during human pregnancy.
Friedman JF; Olveda RM; Mirochnick MH; Bustinduy AL; Elliott AM
Bull World Health Organ; 2018 Jan; 96(1):59-65. PubMed ID: 29403101
[TBL] [Abstract][Full Text] [Related]
40. Schistosoma: a 200-kDa chemotherapeutic target antigen is differentially localized in African vs Oriental species.
Tanaka TM; Skubitz AP; Strand M
Exp Parasitol; 1993 May; 76(3):293-301. PubMed ID: 7684706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
